MassMutual Private Wealth & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.4M Sell
164,347
-3,834
-2% -$825K 1.07% 22
2026
Q1
$36.6M Sell
168,181
-3,394
-2% -$753K 1% 25
2025
Q4
$39.2M Sell
171,575
-5,981
-3% -$1.36M 1.01% 23
2025
Q3
$41.1M Sell
177,556
-3,783
-2% -$770K 1.05% 21
2025
Q2
$33.7M Sell
181,339
-7,018
-4% -$1.3M 0.9% 27
2025
Q1
$39.5M Sell
188,357
-682
-0.4% -$133K 1.14% 19
2024
Q4
$33.6M Sell
189,039
-3,036
-2% -$558K 0.94% 24
2024
Q3
$37.9M Sell
192,075
-1,870
-1% -$349K 1.08% 20
2024
Q2
$33.3M Buy
193,945
+1,566
+0.8% +$259K 1.01% 20
2024
Q1
$35M Sell
192,379
-19,622
-9% -$3.38M 1.09% 20
2023
Q4
$32.9M Buy
212,001
+134
+0.1% +$19.5K 1.1% 22
2023
Q3
$31.6M Sell
211,867
-247
-0.1% -$36.3K 1.17% 20
2023
Q2
$28.6M Buy
212,114
+9,852
+5% +$1.44M 1.03% 22
2023
Q1
$32.2M Buy
202,262
+2,447
+1% +$374K 1.23% 21
2022
Q4
$32.3M Buy
199,815
+1,223
+0.6% +$188K 1.33% 18
2022
Q3
$26.7M Buy
198,592
+211
+0.1% +$30.3K 1.21% 19
2022
Q2
$30.4M Sell
198,381
-20,115
-9% -$3.07M 1.32% 16
2022
Q1
$35.4M Buy
218,496
+651
+0.3% +$94.6K 1.34% 17
2021
Q4
$29.5M Buy
217,845
+3,457
+2% +$408K 1.1% 22
2021
Q3
$23.1M Buy
214,388
+35,334
+20% +$4.04M 0.96% 30
2021
Q2
$20.2M Buy
179,054
+6,618
+4% +$745K 0.86% 33
2021
Q1
$18.7M Buy
172,436
+9,037
+6% +$967K 0.88% 30
2020
Q4
$17.5M Sell
163,399
-2,734
-2% -$263K 0.9% 28
2020
Q3
$14.6M Buy
166,133
+11,694
+8% +$1.1M 0.85% 27
2020
Q2
$15.2M Buy
154,439
+10,059
+7% +$886K 0.98% 23
2020
Q1
$11M Buy
144,380
+657
+0.5% +$56K 0.88% 28
2019
Q4
$12.7M Buy
143,723
+1,938
+1% +$161K 0.79% 26
2019
Q3
$10.7M Buy
141,785
+5,614
+4% +$385K 0.72% 30
2019
Q2
$9.9M Buy
136,171
+3,385
+3% +$266K 0.68% 34
2019
Q1
$10.7M Buy
132,786
+9,042
+7% +$740K 0.77% 29
2018
Q4
$11.4M Sell
123,744
-2,616
-2% -$230K 0.98% 24
2018
Q3
$12M Buy
126,360
+18,611
+17% +$1.76M 0.89% 23
2018
Q2
$9.98M Buy
107,749
+1,012
+0.9% +$98.8K 0.8% 28
2018
Q1
$10.1M Sell
106,737
-1,600
-1% -$176K 0.84% 27
2017
Q4
$10.5M Buy
108,337
+1,571
+1% +$148K 0.87% 25
2017
Q3
$9.49M Buy
106,766
+5,116
+5% +$389K 0.79% 31
2017
Q2
$7.37M Buy
101,650
+2,946
+3% +$198K 0.66% 34
2017
Q1
$6.43M Buy
98,704
+14,194
+17% +$892K 0.6% 41
2016
Q4
$5.29M Buy
+84,510
New +$5.16M 0.65% 37
2016
Q2
$3.84M Buy
61,987
+5,059
+9% +$308K 0.48% 58
2016
Q1
$3.25M Buy
56,928
+6,780
+14% +$378K 0.44% 58
2015
Q4
$2.97M Buy
50,148
+10,426
+26% +$601K 0.42% 64
2015
Q3
$2.29M Buy
39,722
+8,932
+29% +$581K 0.48% 55
2015
Q2
$1.74M Sell
30,790
-14,035
-31% -$916K 0.39% 63
2015
Q1
$2.62M Buy
44,825
+24,506
+121% +$1.48M 0.43% 59
2014
Q4
$1.33M Sell
20,319
-19,403
-49% -$1.22M 0.43% 71
2014
Q3
$2.29M Buy
39,722
+28,515
+254% +$1.58M 0.46% 58
2014
Q2
$633K Buy
11,207
+4,587
+69% +$241K 0.25% 97
2014
Q1
$340K Buy
6,620
+2,214
+50% +$112K 0.2% 104
2013
Q4
$233K Buy
+4,406
New +$217K 0.21% 95

Other funds holding ABBV

MassMutual Private Wealth & Trust's ABBV Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $825K and leaving 164,347 shares worth $41.4M. The position accounts for 1.07% of the portfolio, ranked #22.

MassMutual Private Wealth & Trust first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. 2,127 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MassMutual Private Wealth & Trust held 164,347 shares of AbbVie worth $41.4M as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 3,834 AbbVie shares in Q2 2026, an estimated $825K.
  • AbbVie made up 1.07% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #22 holding.
  • MassMutual Private Wealth & Trust first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • 2,127 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.